Details for New Drug Application (NDA): 021132
✉ Email this page to a colleague
The generic ingredient in ZYVOX is linezolid. There are twenty-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the linezolid profile page.
Suppliers and Packaging for NDA: 021132
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYVOX | linezolid | FOR SUSPENSION;ORAL | 021132 | NDA | Pharmacia & Upjohn Company LLC | 0009-5136 | 0009-5136-01 | 150 mL in 1 BOTTLE (0009-5136-01) |
ZYVOX | linezolid | FOR SUSPENSION;ORAL | 021132 | NDA | Pharmacia & Upjohn Company LLC | 0009-5136 | 0009-5136-04 | 150 mL in 1 BOTTLE (0009-5136-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Apr 18, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021132
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | ZYVOX | linezolid | FOR SUSPENSION;ORAL | 021132-001 | Apr 18, 2000 | 5,688,792*PED | ⤷ Subscribe |
Pfizer | ZYVOX | linezolid | FOR SUSPENSION;ORAL | 021132-001 | Apr 18, 2000 | 6,559,305*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription